YC Companies/Summer 2022/Signatur Biosciences
Signatur Biosciences logo

Signatur Biosciences

Simple tests for complex diseases.

Summer 2022Healthcare / Healthcare -> DiagnosticsLondon, England, United Kingdom5 employees
Biotech
Healthcare
Diagnostics

About

We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Celestin de Wergifosse
Founder
John Goertz
Founder

Details

Status
Active
Stage
Early
Team Size
5
Regions
United Kingdom, Europe, Remote, Partly Remote